These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19403757)

  • 1. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure.
    Biswas S; Miguel RN; Sukla S; Field HJ
    J Gen Virol; 2009 Aug; 90(Pt 8):1937-1942. PubMed ID: 19403757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.
    Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ
    Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target.
    Biswas S; Kleymann G; Swift M; Tiley LS; Lyall J; Aguirre-Hernández J; Field HJ
    J Antimicrob Chemother; 2008 May; 61(5):1044-7. PubMed ID: 18299638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
    Biswas S; Jennens L; Field HJ
    Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.
    Sato Y; Suenaga T; Kobayashi M; Miyazaki N; Suzuki T; Ishioka K; Suzutani T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0049421. PubMed ID: 34228537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant.
    Sukla S; Biswas S; Birkmann A; Lischka P; Ruebsamen-Schaeff H; Zimmermann H; Field HJ
    Antiviral Res; 2010 Jul; 87(1):67-73. PubMed ID: 20420855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the human herpes simplex virus type 1 UL52 zinc finger motif results in defective primase activity but can recruit viral polymerase and support viral replication efficiently.
    Chen Y; Livingston CM; Carrington-Lawrence SD; Bai P; Weller SK
    J Virol; 2007 Aug; 81(16):8742-51. PubMed ID: 17553899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance.
    Muylaert I; Zhao Z; Elias P
    J Biol Chem; 2014 Nov; 289(47):32583-92. PubMed ID: 25278021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The three-component helicase/primase complex of herpes simplex virus-1.
    Bermek O; Williams RS
    Open Biol; 2021 Jun; 11(6):210011. PubMed ID: 34102080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor.
    Sukla S; Biswas S; Birkmann A; Lischka P; Zimmermann H; Field HJ
    J Antimicrob Chemother; 2010 Jul; 65(7):1347-52. PubMed ID: 20453068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of gly815 in helicase motif V alters the single-stranded DNA-dependent ATPase activity of the herpes simplex virus type 1 helicase-primase.
    Graves-Woodward KL; Weller SK
    J Biol Chem; 1996 Jun; 271(23):13629-35. PubMed ID: 8662872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.
    Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG
    Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1.
    Biswas S; Smith C; Field HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):274-9. PubMed ID: 17550887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-hybrid analysis of the interaction between the UL52 and UL8 subunits of the herpes simplex virus type 1 helicase-primase.
    Constantin N; Dodson MS
    J Gen Virol; 1999 Sep; 80 ( Pt 9)():2411-2415. PubMed ID: 10501495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity.
    Klinedinst DK; Challberg MD
    J Virol; 1994 Jun; 68(6):3693-701. PubMed ID: 8189507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of polymerase to herpes simplex virus type 1 replication foci in cells expressing mutant primase (UL52) proteins.
    Carrington-Lawrence SD; Weller SK
    J Virol; 2003 Apr; 77(7):4237-47. PubMed ID: 12634381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the Phosphorylation of Herpes Simplex Virus 1 UL51 at a Specific Site in Viral Replication and Pathogenicity.
    Kato A; Oda S; Watanabe M; Oyama M; Kozuka-Hata H; Koyanagi N; Maruzuru Y; Arii J; Kawaguchi Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.